June 16, 2011
CONRAD and the South African Government's Technology Innovation Agency (TIA) on Tuesday announced a license agreement that grants TIA the rights to manufacture and distribute tenofovir gel in Africa, according to a CONRAD statement. TIA also will establish a joint venture with drug maker Cipla Medpro and iThemba Pharmaceuticals for the registration, manufacturing and distribution of the gel in South Africa and other African nations (6/14). A large trial of tenofovir gel among women was also announced on Tuesday (6/15).
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.